As suggested by Wang et al., CircMTO1 overexpression inhibited the TGF-β1-mediated HSC activation and cell cycle progression, suppressed α-SMA and type I collagen levels, and relieved liver fibrosis through targeting miR-17-5p and Smad7 [6]. Here, SMAD7 is linked to Hepatic fibrosis.